Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

CRISPR01:59

CRISPR

52.3K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
52.3K
CRISPR/Cas9 Genome Editing01:28

CRISPR/Cas9 Genome Editing

54
The CRISPR-Cas system serves as a bacterial defense mechanism against invading genetic elements such as viruses and plasmids, forming the foundation for its adaptation as a powerful genome-editing tool. Originally discovered in prokaryotes, this system has been repurposed to revolutionize genetic engineering across a wide range of organisms, including plants, animals, and humans. The core component, Cas9, is an endonuclease derived from Streptococcus pyogenes, capable of introducing...
54
In-vitro Mutagenesis01:16

In-vitro Mutagenesis

14.0K
To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.
14.0K
CRISPR and crRNAs02:53

CRISPR and crRNAs

17.1K
Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
17.1K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Harmonizing standards and resources for the medical genome.

Nature·2026
Same author

Arrayed dual-gRNA CRISPR screening platform for <i>C9orf72</i> repeat expansion excision in patient iPSCs.

Molecular therapy. Advances·2026
Same author

Development of a Fully Non-Viral 1XX-enhanced BCMA CAR-T Cell Therapy for Multiple Myeloma.

bioRxiv : the preprint server for biology·2026
Same author

Novel Missense Variants in <i>TRIM37</i> Associated with Mulibrey Nanism and Complex Congenital Heart Disease.

Cardiology and cardiovascular medicine·2026
Same author

Interventional genomics: Bridging germline diagnosis and therapeutic action.

Genetics in medicine : official journal of the American College of Medical Genetics·2026
Same author

Microfluidic capillary transit velocity as a functional measure for sickle cell disease and <i>in vitro</i>-derived red blood cells.

Lab on a chip·2026
Same journal

Assessing Human Epidermal Growth Factor Receptor 2 in Urothelial Carcinoma: Insights From Clinical Practice Into Scoring Criteria, Histologic Subtypes, and Genomic Characteristics Across Disease Sites.

Archives of pathology & laboratory medicine·2026
Same journal

Cross-Reactivity of TPIT Antibody Clone OTI2G1 in Chordoma: Structural Mechanisms and Diagnostic Implications.

Archives of pathology & laboratory medicine·2026
Same journal

Paracoccidioidomycosis at Autopsy: A Case Series and Literature Review.

Archives of pathology & laboratory medicine·2026
Same journal

Accuracy of Cytology Diagnosis for Well Differentiated Neuroendocrine Tumors: Assessment by the College of American Pathologists Non-Gynecologic Slide Program.

Archives of pathology & laboratory medicine·2026
Same journal

Serum Immunofixation Electrophoresis Guidance Conflict: A Call to Harmonize.

Archives of pathology & laboratory medicine·2026
Same journal

In Reply.

Archives of pathology & laboratory medicine·2026
查看所有相关文章

相关实验视频

Updated: Jul 18, 2025

Genome Editing in Mammalian Cell Lines using CRISPR-Cas
07:56

Genome Editing in Mammalian Cell Lines using CRISPR-Cas

Published on: April 11, 2019

21.8K

一本关于基因编辑的入门书.

Allison Cushman-Vokoun1, Ryan J Schmidt2,3, Matthew Charles Hiemenz4

  • 1From the Department of Pathology & Microbiology, University of Nebraska Medical Center, Omaha (Cushman-Vokoun).

Archives of pathology & laboratory medicine
|August 21, 2023
PubMed
概括
此摘要是机器生成的。

基因编辑疗法在医学中提供了变革性的潜力,但需要病理学家的参与. 这篇教育论文旨在为病理学家提供有关基因编辑技术,风险及其在诊断和治疗监测中的作用的知识.

更多相关视频

CRISPR/Cas9 Editing of the C. elegans rbm-3.2 Gene using the dpy-10 Co-CRISPR Screening Marker and Assembled Ribonucleoprotein Complexes.
07:46

CRISPR/Cas9 Editing of the C. elegans rbm-3.2 Gene using the dpy-10 Co-CRISPR Screening Marker and Assembled Ribonucleoprotein Complexes.

Published on: December 11, 2020

5.9K
Generating CRISPR/Cas9 Mediated Monoallelic Deletions to Study Enhancer Function in Mouse Embryonic Stem Cells
11:31

Generating CRISPR/Cas9 Mediated Monoallelic Deletions to Study Enhancer Function in Mouse Embryonic Stem Cells

Published on: April 2, 2016

14.2K

相关实验视频

Last Updated: Jul 18, 2025

Genome Editing in Mammalian Cell Lines using CRISPR-Cas
07:56

Genome Editing in Mammalian Cell Lines using CRISPR-Cas

Published on: April 11, 2019

21.8K
CRISPR/Cas9 Editing of the C. elegans rbm-3.2 Gene using the dpy-10 Co-CRISPR Screening Marker and Assembled Ribonucleoprotein Complexes.
07:46

CRISPR/Cas9 Editing of the C. elegans rbm-3.2 Gene using the dpy-10 Co-CRISPR Screening Marker and Assembled Ribonucleoprotein Complexes.

Published on: December 11, 2020

5.9K
Generating CRISPR/Cas9 Mediated Monoallelic Deletions to Study Enhancer Function in Mouse Embryonic Stem Cells
11:31

Generating CRISPR/Cas9 Mediated Monoallelic Deletions to Study Enhancer Function in Mouse Embryonic Stem Cells

Published on: April 2, 2016

14.2K

科学领域:

  • * 探索基因编辑技术及其在医学中的应用.
  • *专注于先进生物技术和临床实践的交集.

背景情况:

  • *基因编辑疗法正在用于瘤学,遗传性疾病和传染病.
  • *这些进步源于自然原则,但引发了有关风险,成本和道德方面的担忧.

研究的目的:

  • *教育病理学家关于基因编辑技术,说明和风险.
  • * 提供有关影响实验室医学的监管和实践问题的信息.
  • * 倡导病理学家参与基因编辑讨论.

主要方法:

  • *召集由病理学家组成的基因编辑工作组.
  • * 由美国病理学家学院个人化医疗保健委员会提供便利.
  • * 文献审查和小组讨论以确定知识差距.

主要成果:

  • * 在病理学家对基因编辑的理解中发现了差距.
  • *总结了影响病理学和实验室医学的主要主题.
  • *强调了需要病理学家作为基因编辑实施的利益相关者.

结论:

  • *基因编辑是一个复杂而变革性的医学领域.
  • * 这篇文章是病理学家的介绍.
  • *旨在促进有根据的讨论和潜在的病理学实践调整.